Surgical management of hereditary colorectal cancer: Surgery based on molecular analysis and family history

Revista Espanola de Enfermedades Digestivas

Volumn 101, Issue 8, 2009, Pages 536-540

  Perea García, José ^a   Justo, I ^a   Alvaro E ^a   Lomas, M ^a   Diaz Tasende J ^a   Marin J C ^a   Franco, A ^a   Colina, F ^a   Rodriguez Y ^a   Martinez J ^a   Robles, L ^a   Urioste, M ^b   Hidalgo, M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Centro Nacional de Investigations Oncológicas   (Spain)

Author keywords

Colorectal cancer; Familial adenomatous polyposis; Familial colorectal cancer type X; Lynch syndrome; Surgery

Indexed keywords

APC PROTEIN; PROTEIN MSH2;

ADENOCARCINOMA; ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; COLON BIOPSY; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; MALE; PEDIGREE ANALYSIS;

ADENOMATOUS POLYPOSIS COLI; ADULT; AGE FACTORS; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; FEMALE; GENETIC COUNSELING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MUTATION; PEDIGREE; PROCTOCOLECTOMY, RESTORATIVE;

EID: 74849117329     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. La situación del cáncer en España. Madrid: Ministerio de Sanidad y Consumo; 2005.
2. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005; 293: 1979-85.
3. Valle L, Perea J, Carbonell P, Fernández V, Dotor AM, Benítez J, et al. Clinicopathological and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 2007; 25(7): 781-6.
4. Llor X, Pons E, Xicola RM, Castells A, Alenda C, Piñol V, et al. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 2005; 11: 7304-10.
5. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006; 101(2): 385-98.
6. Mecklin JP, Aarnio M, Läärä E, Kairaluoma MV, Pylvänäinen K, Peltomäki P, et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 2007; 133(4): 1093-8.
7. Vasen HF, Möslein G, Alonso A, Bernstein I, Bertario L, Blanco I, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44(6): 353-62.
8. You YN, Lakhani VT, Wells SA Jr. The role of prophylactic surgery in cancer prevention. World J Surg 2007; 31(3): 450-64.
9. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58(22): 5248-57.
10. De Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, Menko FH, Taal BG, Kleibeuker JH, et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long term study on 114 families. Dis Colon Rectum 2002; 45: 1588-94.
11. De Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 2003; 52: 1752-5.
12. Guillem JG, Smith AJ, Calle JP, Ruo. Gastrointestinal polyposis syndromes. Curr Probl Surg 1999; 36(4): 217-323.
13. Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, Mead LJ, et al. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 2006; 4(4): 489-98.
14. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006; 296(12): 1507-17.
15. Jover R, Castells A. Molecular information defines a new entity of hereditary colorectal cancer. Gastroenterology 2008; 134(3): 888-9.
16. Valle L, Urioste M. Molecular information defines a new entity of hereditary colorectal cancer (Reply). Gastroenterology 2008; 134(3): 889-90.
17. Kashiwagi H, Spigelman AD. Gastroduodenal lesions in familial adenomatous polyposis. Surg Today 2000; 30(8): 675-82.
18. Herráiz M, Muñoz-Navas M. Recognition and management of hereditary colorectal cancer syndromes. Rev Es Enferm Dig 2009; 101(2): 125-32.
19. Cordero Fernández C, Pizarro Moreno A, Garzón Benavides M, García-Lozano R, Belda Laguna O, Sobrino S, et al. Follow-up alter surgical treatment of patients with familial adenomatous polyposis: results in a southern Spanish population. Rev Esp Enferm Dig 2007; 99(8): 440-5.
20. Bixquert M. Adherence to a postoperative follow-up protocol in patients with familial adenomatous polyposis may prevent colorectal cancer development. Rev Es Enferm Dig 2007; 99(8): 433-7.
21. Church J. In which patients do I perform IRA, and why? Fam Cancer 2006; 5: 237-40.
22. Al-Sukhni W, Aronson M, Gallinger S. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and Lynch syndrome. In: Jatoi I, Martin RF, eds. Hereditary Cancer Syndromes. Surg Clin North Am 2008; 88(4): 819-42.
23. Kartheuser A, Stangherlin P, Brandt D, Remue C, Sempoux C. Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer 2006; 5(3): 241-60.